SCHEMBL1067013

SCHEMBL1067013

O=C(O)C(O)c1cn([C@H]2O[C@@H](CO)C(O)C2O)c(=S)[nH]c1=O

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PYGM P11217 3/20 0.52
SLC28A1 O00337 1/20 0.46
SLC28A2 O43868 1/20 0.46
SLC29A1 Q99808 1/20 0.46
SLC28A3 Q9HAS3 1/20 0.46
TK2 O00142 2/20 0.46
P2RY2 P41231 1/20 0.43
HPGD P15428 1/20 0.42
CDA P32320 3/20 0.42
MAPT P10636 1/20 0.42
PAX8 Q06710 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18512917 0.88 PYGM (0.63) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL40820 0.88 PYGM (0.63) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL40819 0.88 PYGM (0.63) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL18503568 0.88 PYGM (0.63) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL18512919 0.88 PYGM (0.63) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL27760732 0.88 PYGM (0.51) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL441977 0.85 PYGM (0.48) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL21683245 0.85 PYGM (0.48) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL20534354 0.85 PYGM (0.48) PYGMSLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL3841360 0.85 PYGM (0.48) PYGMSLC28A1SLC28A2SLC29A1SLC28A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110014214-A1 Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2011-01-20 US disclosed
US-7501281-B2 Compositions, methods and kits related to thrombin, Notch signaling and stamatogenesis and growth of stem cells MAINE MEDICAL CENTER RESEARCH INSTITUTE (US) 2009-03-10 US disclosed
US-7304138-B2 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids MAINE MEDICAL CENTER RESEARCH INSTITUTE (US) 2007-12-04 US disclosed
WO-2007084757-A2 DIAGNOSTIC AND THERAPEUTIC UTILITY OF TRIBBLES-2 IN HUMAN CANCERS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-07-26 WO disclosed
WO-2006125001-A2 COMPOSITIONS AND METHODS RELATED TO THE INTRACELLULAR EFFECTS OF INTRACELLULAR DOMAINS OF DELTA1 AND JAGGED1 MAINE MEDICAL CENTER RESEARCH INSTITUTE (US) 2006-11-23 WO disclosed
US-20060084599-A1 Compositions, methods and kits relating to notch signaling MAINE MEDICAL CENTER 2006-04-20 US disclosed
US-20060063253-A1 Compositions, methods and kits relating to thrombin, Notch signaling and stamatogenesis and growth of stem cells MAINE MEDICAL CENTER RESEARCH INSTITUTE 2006-03-23 US disclosed
US-20040253602-A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids MAINE MEDICAL CENTER RESEARCH INSTITUTE 2004-12-16 US disclosed
WO-2004078944-A2 THROMBIN, SOLUBLE JAGGEDI, AND TRAP AND GROWTH OF STEM CELLS MAINE MEDICAL CENTER RESEARCH INSTITUTE (US) 2004-09-16 WO disclosed
US-6716974-B1 THE ADDITION OR INCREASED EXPRESSION OF JAGGED DECREASES THE MIGRATION AND INVASION OF MICROVASCULAR CELLS FROM THE VASO VASORUM, AND INCREASES OR STIMULATES THE MIGRATION OF LARGE VESSEL ENDOTHELIAL CELLS. MAINE MEDICAL CENTER RESEARCH INSTITUTE 2004-04-06 US disclosed